In patent application 06127987, Sirtris discusses and shares data on the bioavailability of various resveratrol formulations, including the putative SRT501. I've excerpted several figures from that document below.
The first shows plasma resveratrol concentrations in mice after oral dosing with either 'unprocessed' resveratrol, which has a meam particle size of thirteen microns, or micronized resveratrol (one micron particles) mixed with HPMC (hydroxypropylmethyl cellulose) or HPMC and DOSS (dioctyl sodium sulfosuccinate). In the second part of this figure, they compare oral dosing of the micronized/HPM/DOSS to a TWEEN 80 based preparation. Dosages in all cases are very high.
You can see that the inclusion of excipients, most dramatically here Tween 80, gives a markedly higher peak serum concentration. The Tween 80 peak is quite impressive.
Figure 1
Next let's look at Oral vs IP dosing in mice. You can seen that IP dosing gives much higher peak serum levels.
Figure 2
Now we have some rat data. We're comparing plasma levels for IP versus oral dosing, focusing this time on the Captisol formulation, which is the putative SRT501 based on text in the patent application. Also importantly, we're looking at mostly 50mg/kg doses here instead of 400-600. Again we see that IP administration gives higher concentrations. We also see that the Captisol formulation gives a sharper oral dosage curve, but a lower total area under the curve.
Figure 3
Some thoughts:
Personally, my desired target for serum plasma levels is on the order of 5-10 um. This is what I believe is necessary to get devent Sirt1 activation. If you are a rodent, you can achieve this by oral administration of either ~500mg/kg of raw resvertrol, or something on the order of 100mg/kg or micronized resveratrol prepared with solubilizing agents. Most intriguingly, you may be able to get to these concentrations at a lowly 20mg/kg if the excipient is Tween 80. Thus, a human dose of 1-2 grams in Tween 80 may be quite effective.
Also interesting, we see that an oral dosage of 50mg/kg in rats as the Captisol admixture gives ~6um peak serum levels. This is approximately the dosage used in the SRT501 trials, and this mixture very well may be SRT501 itself, based on some other information in the patent application.
Regarding Tween80, this material is considered consumable and is present in a lot of food preparations. Moreover, it can be obtained fairly cheaply from Sigma or other suppliers. I'm not sure what maximal quantities one can take; at some point it should probably be a laxative. I expect several grams would be safe, however.
I'm going to attempt to make some of these formulations, particularly the Tween form. I'll keep you all posted on how it goes.
Edited by proteomist, 21 May 2007 - 05:49 AM.